bifendate has been researched along with Chronic Hepatitis B in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, S; Fan, G; Wang, M | 1 |
| Hao, B; Liu, G; Roger, H; Wu, T; Xie, L | 1 |
| Kim, SG; Kim, YM; Lee, MH | 1 |
1 review(s) available for bifendate and Chronic Hepatitis B
| Article | Year |
|---|---|
Bicyclol for chronic hepatitis B.
Topics: Biphenyl Compounds; Hepatitis B, Chronic; Humans | 2006 |
2 trial(s) available for bifendate and Chronic Hepatitis B
| Article | Year |
|---|---|
[Anti-HBV efficacy of bifendate in treatment of chronic hepatitis B, a primary study].
Topics: Adult; Antiviral Agents; Biphenyl Compounds; Female; Hepatitis B, Chronic; Humans; Liver; Male; Treatment Outcome | 2002 |
Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Allyl Compounds; Aspartate Aminotransferases; Biomarkers; Capsules; Dioxoles; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver; Male; Middle Aged; Protective Agents; Republic of Korea; Sulfides; Time Factors; Treatment Outcome | 2012 |